Skip to content

Xen 45 implant versus Deep Sclerectomy in the surgical treatment of open angle glaucoma: A comparative study in a South African tertiary hospital

Xen 45 implant versus Deep Sclerectomy in the surgical treatment of open angle glaucoma: A comparative study in a South African tertiary hospital

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201906908757116
Enrollment
12
Registered
2019-06-06
Start date
2019-05-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Xen 45 implant
Deep sclerectomy with mitomycin C

Sponsors

University of the Witwatersrand Faculty of Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • CMJAH eye clinic adult patients (18 years of age or older) • Bilateral open angle glaucoma (primary open-angle glaucoma (POAG), exfoliation glaucoma (XFG) or pigment dispersion syndrome (PDS)) requiring surgery to both eyes: o GLAUCOMA DIAGNOSIS will be based on the appearance of the optic nerve head, open angles on gonioscopy, optical coherence tomography (OCT) structural assessments and humphrey visual field changes o REQUIREMENTS FOR SURGERY: ? IOP greater than 18mmHg despite maximal tolerated medical therapy ? Progression of optic nerve cupping, thinning of the retinal nerve fibre layer or progression of visual field defects despite maximal tolerated medical therapy

Exclusion criteria

Exclusion criteria: • Post-traumatic and angle-recession glaucoma • Neovascular glaucoma • Uveitic glaucoma • Occludable angles on gonioscopy • Previous intra-ocular surgery other than uncomplicated cataract surgery • Prior conjunctival surgery or pathology • Active inflammation (blepharitis, conjunctivitis, keratitis, uveitis) • Impaired episcleral venous pressure (for example Sturge-Weber syndrome, nanophthalmos or thyroid eye diseases

Design outcomes

Primary

MeasureTime frame
1.Cost •Surgical time •Disposables and devices •Post-operative medication •Follow-up visits •Additional procedures

Secondary

MeasureTime frame
Intraocular pressure ;Success • A COMPLETE SUCCESS will be defined as an IOP of less than or equal to 18mmHg and an IOP reduction greater than or equal to 30% without glaucoma medication or compared with a pre-operative level. In addition there must be no progression of optic nerve cupping or visual field changes • A QUALIFIED SUCCESS will be defined as an IOP less than or equal to 18mmHg with glaucoma medication or an IOP reduction of less than 30% compared with a pre-operative level in the absence of glaucoma progression • A QUALIFIED FAILURE will be defined as an IOP greater than 18mmHg despite glaucoma medication but without detectable optic nerve or visual field deterioration • A COMPLETE FAILURE will be an eye requiring a second glaucoma drainage surgery or losing visual function;Number of glaucoma medications used

Countries

South Africa

Contacts

Public ContactSusan Williams

Lecturer

susan.williams@wits.ac.za+27824676999

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026